Arcadia Biosciences earnings were -$2.0M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest RKDA earnings report on Mar 31, 2025 announced Q1 2025 earnings of $2.6M, down 164% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RKDA reported annual earnings of -$7.0M, with -49.7% growth.
Arcadia Biosciences Earnings Reports & History FAQ
What were Arcadia Biosciences's earnings last quarter?
On RKDA's earnings call on Invalid Date, Arcadia Biosciences (NASDAQ: RKDA) reported Q1 2025 earnings per share (EPS) of $1.90, up 206.74% year over year. Total RKDA earnings for the quarter were $2.60 million. In the same quarter last year, Arcadia Biosciences's earnings per share (EPS) was -$1.78.
Is Arcadia Biosciences profitable or losing money?
As of the last Arcadia Biosciences earnings report, Arcadia Biosciences is currently losing money. Arcadia Biosciences's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$2.02 million, a 71.28% decrease year over year.
What was RKDA's earnings growth in the past year?
As of Arcadia Biosciences's earnings date in Invalid Date, Arcadia Biosciences's earnings has grown year over year. RKDA earnings in the past year totalled -$2.02 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.